Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica’s InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial

NEXT STORY
Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
PREV STORY
Principia Announces Expanded Development Program to Broaden BTK Footprint in Immune-Mediated Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

In-Vitro Diagnostics (IVD) Market Worth $118.5 Billion by 2027 – Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

author_avatar
NASDAQ Market News

Insights on the PCR and NGS-based Diagnostics Global Market to 2027 – Featuring Abbott Laboratories, Thermo Fisher Scientific and Illumina Among Others

author_avatar
NASDAQ Market News

Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients’ quality of life

Findings from more than 1,300 patients across 13 countries showed ITP had especially high ...

author_avatar
NASDAQ Market News